Neuroprotective properties of standardized extracts of hypericum perforatum on rotenone model of parkinson's disease

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 5, 2013, Pages 665-679

  Gomez del Rio M A ^a   Sanchez Reus M I ^a   Iglesias, I ^a   Pozo, M A ^a   Garcia Arencibia M ^a,b,c   Fernandez Ruiz J ^a,b,c   Garcia Garcia L ^a   Delgado, M ^a   Benedi J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

Author keywords

Hypericum perforatum; Neuroprotective effects; Parkinson disease; Rotenone

Indexed keywords

CASPASE 3; DOPAMINE; FLUORODEOXYGLUCOSE F 18; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; NEUROTRANSMITTER; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; QUERCETIN; ROTENONE;

AKINESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRADYKINESIA; CATALEPSY; CELL DEATH; CONTROLLED STUDY; DRUG MEGADOSE; FORCED SWIMMING TEST; HYPERICUM PERFORATUM; LOW DRUG DOSE; MALE; MUSCLE TONE; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; RAT; WESTERN BLOTTING;

EID: 84882773171     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311312050013     Document Type: Article

References (67)

1. Zbarsky, V.; Datla, K.P.; Parkar, S.; Rai, D.K.; Aruoma, O.I.; Dexter, D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res., 2005, 39, 1119-1125.
2. Xiong, N.; Huang, J.; Zhang, Z.; Zhang, Z.; Xiong, J.; Liu, X.; Jia, M.; Wang, F.; Chen, C.; Cao, X.; Liang, Z.; Sun, S.; Lin, Z.; Wang, T. Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease. PLoS One, 2009, 4, e7878.
3. Moon, Y.; Lee, K.H.; Park, J.H.; Geum, D.; Kim, K. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10. J. Neurochem., 2005, 93, 1199-1208.
4. Wang, X.F.; Li, S.; Chou, A.P.; Bronstein, J.M. Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease. Neurobiol Dis.; 2006, 23, 198-205.
5. Koopman, W.J.; Nijtmans, L.G.; Dieteren, C.E.; Roestenberg, P.; Valsecchi, F, Smeitink, J.A.; Willems P.H. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal., 2010, 12, 1431-1470.
6. Tahara, E.B.; Navarete, F.D.; Kowaltowski, A.J. Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic. Biol. Med., 2009,46,1283-1297.
7. Anbuselvam, C.; Vijayavel, K.; Balasubramanian, M.P. Protective effect of Operculina turpethum against 7,12-dimethyl benz(a)anthracene induced oxidative stress with reference to breast cancer in experimental rats. Chem. Biol. Interact., 2007, 168, 229-236.
8. Abdin, A.; Sarhan, N. Intervention of mitochondrial dysfunctionoxidative Stress-dependent apoptosis as a possible neuroprotective mechanism of a-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity. Neurosci. Res., 2011, 71, 387-395.
9. Zheleva-Dimitrova, D.; Nedialkov, P.; Kitanov, G. Radical scavenging and antioxidant activities of methanolic extracts from Hypericum species growing in Bulgaria. Pharmacogn. Mag., 2010, 6, 74-78.
10. Benedí, J.; Arroyo, R.; Romero, C.; Martín-Aragón, S.; Villar, A.M. Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxide-induced oxidative damage in PC12 cells. Life Sci., 2004, 75, 1263-1276.
11. Kumar, A.; Singh, A. Protective effect of St. John's Wort (Hypericum perforatum) extract on 72-hour sleep deprivationinduced anxiety-like behavior and oxidative damage in mice. Planta Med., 2007, 73,1358-1364.
12. Singh, A.; Naidu, P.S.; Gupta, S.; Kulkarni, S.K. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J. Med. Food, 2002, 5,211-220.
13. Zou, Y.; Lu, Y.; Wei, D. Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro. J. Agric. Food Chem., 2004, 52, 5032-5039.
14. El Sherbiny, D.A.; Khalifa, A.E.; Attia, A.S.; el Eldenshary, E. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol. Biochem. Behav., 2003, 76, 525-533.
15. Sánchez-Reus, M.I; Gómez Del Río, M.A.; Iglesias, I.; Elorza, M.; Slowing, K, Benedí, J. Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats. Neuropharmacology., 2007, 52, 606-616.
16. Silva, B.A.; Dias, A.C.; Ferreres, F.; Malva, J.O.; Oliveira, C.R. Neuroprotective effect of H. perforatum extracts on beta-amyloidinduced neurotoxicity. Neurotox Res.; 2004, 6,119-130.
17. Zou, Y.; Lu, Y.; Wei, D. Hypocholesterolemic effects of a flavonoid-rich extract of Hypericum perforatum L. in rats fed a cholesterol-rich diet. J. Agric. Food Chem., 2005, 53,2462-2426.
18. Silva, B.; Oliveira, P.J.; Dias, A.; Malva, J.O. Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotective against excitotoxic insults. Neurotox. Res., 2008, 13, 265-267.
19. Muñoz, M.; Bermejo-Bescós, P.; Romero, C.; Benedí, J.; Martín- Aragón, S. SNP-Mediated Neuroprotection Under Glucose Deprivation is Enhanced by Hypericum Perforatum. CNS Neurol. Disord. Drug Target, 2012, 11,162-173.
20. Sriraksa, N.; Wattanathorn, J.; Muchimapura, S.; Tiamkao, S.; Brown, K.; Chaisiwamongkol, K. Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6- hydroxydopamine. Evid. Based Complement Alternat. Med., 2012, doi:10.1155/2012/823206.
21. Youdim, K.A.; Shukitt-Hale, B.; Joseph, J.A. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic. Biol. Med., 2004, 37, 683-693.
22. Azuma, K.; Ippoushi, K.; Ito, H.; Horie, H.; Terão, J. Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats. Biosci. Biotechnol. Biochem., 2003, 67, 2548-2555.
23. Priprem, A.; Watanatorn, J.; Sutthiparinyanont, S.; Phachonpai, W.; Muchimapura, S. Anxiety and cognitive effects of quercetin liposomes in rats. Nanomedicine, 2008, 4,70-78.
24. Rivera, F.; Urbanavicius, J.; Gervaz, E.; Morquio, A.; Dajas, F. Some aspects of the in vivo neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship. Neurotox. Res., 2004, 6, 543-553.
25. Griffith, T.N.; Varela-Nallar, L.; Dinamarca, M.C.; Inestrosa, N.C. Neurobiological effects of Hyperforin and its potential in Alzheimer's disease therapy. Curr. Med. Chem., 2010, 17, 391-406.
26. Klusa, V.; Germane, S.; Noldner, M.; Chatterjee, S.S. Hypericum extract and hyperforin: memory-enhancing properties in rodents. Pharmacopsychiatry, 2001, 34, S61-S69.
27. Zanoli, P. Role of hyperforin in the pharmacological activities of St. John's Wort. CNS Drug Rev., 2004, 10, 203-218.
28. Chatterjee, S.S.; Bhattacharya, S.K.; Wonnemann, M.; Singer, A.; Muller, W.E. Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci., 1998, 63,499-510.
29. Khalifa, A.E. Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. J. Ethnopharmacol., 2001, 76, 49-57.
30. Bangham, A.D.; Standish, M.M.; Watkins, J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol., 1965, 13, 238-252.
31. Haobam, R.; Sindhu, K.M.; Chandra, G.; Mohanakumar, K.P. Swim-Test as a function of motor impairment in mptp model of Parkinson'S disease: A comparative study in two mouse strains. Behav. Brain Res., 2005, 16, 159-167.
32. Alam, M.; Schmidt, W.J. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behav. Brain Res., 2004, 153, 439-446.
33. Sobrado, M.; Delgado, M.; Fernández-Valle, E.; García-García, L.; Torres, M.; Sánchez-Prieto, J.; Vivancos, J.; Manzanares, R.; Moro, M.A.; Pozo, M.A.; Lizasoain, I. Longitudinal studies of ischemic penumbra by using 18F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats. Neuroimage, 2011, 57, 45-54.
34. Sindhu, K.M.; Saravanan, K.S.; Mohanakumar, K.P. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed followig intranigral or media forebrain bundle infusion. Brain Res., 2005,105, 25-34.
35. González, S.; Romero, J.; de Miguel, R.; Lastres-Becker, I.; Villanua, M.A.; Makriyannis, A.; Ramos, J.A.; Fernández-Ruiz, J.J. Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide. Life Sci., 1999, 65, 327-336.
36. Paxinos, G., and Watson, C. The Rat Brain in Stereotaxic Co- Ordinates, Academic. Press, San Diego; 1986.
37. Chen, R.W.; Chuang, D.M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J. Biol. Chem., 1999, 274, 6039-6042.
38. Bijur, G.N.; De Sarno, P.; Jope, R.S. Glycogen synthase kinase-3 beta facilitates staurosporine- and heat shock- induced apoptosisprotection by lithium. J Biol Chem., 2000, 275, 7583-7590.
39. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem., 1976, 72, 248-254.
40. Sánchez-Reus, M.I.; Peinado, I.; Molina-Jiménez, M.F.; Benedí, J. Fraxetin prevents rotenone-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells. Neurosci. Res., 2005, 53, 48-56.
41. Marks, N.; Berg, M.J.; Guidotti, A.; Saito, M. Activation of caspase-3 and apoptosis in cerebellar granule cells. J. Neurosci., 1998, 52, 334-341.
42. Brown, T.P.; Rumsby, P.C.; Capleton, A.C.; Rushton, L.; Levy, L.S. Pesticides and Parkinson's disease--is there a link? Environ. Health Perspect., 2006, 114, 156-164.
43. Cicchetti, F.; Drouin-Ouellet, J.; Gross, R.E. Environmental toxins and parkinson's disease: what have we learned from pesticideinduced animal models? Trends Pharmacol. Sci.; 2009, 30,475-483.
44. Cannon, J.R.; Tapias, V.; Na, H.M.; Honick, A.S.; Drolet, R.E.; Greenamyre, J.T. A highly reproducible rotenone model of Parkinson's disease. Neurobiol. Dis., 2009, 34, 279-290.
45. Levy, O.A,; Malagelada, C.; Greene, L.A. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis, 2009, 14, 478-500.
46. Kelsey, N.A.; Wilkins, H.M.; Linseman, D.A. Nutraceutical antioxidants as novel neuroprotective agents. Molecules, 2010, 15, 7792-814.
47. Liang, P.L.; Patel, M. Seizure-induced changes in mitochondrial redox status. Free Radic. Biol. Med., 2006, 40, 316-322.
48. Mohanasundari, M.; Srinivasan, M.S.; Sethupathy, S.; Sabesan, M. Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against mptp-induced neurotoxicity in mice. J. Neurol. Sci., 2006, 249, 140-144.
49. Cervo, L.; Rozio, M.; Ekalle-Soppp, C.B.; Guiso, G.; Morazzon, P.; Caccia, S. Role of hyperforin in the antidepressant-like activity of Hypericum Perforatum extracts. Psychopharmacology, 2002, 164, 423-428.
50. Mehdizadeh, M.; Joghataei, M.T.; Nobakht, M.; Aryanpour, R. The beneficial effect of the flavonoid quercetin on behavioral changes in hemi-Parkinsonian rats. BCN, 2009, 1, 30-32.
51. Müller, W.E. Current St John's wort research from mode of action to clinical efficacy. Pharmacol. Res., 2003, 4,101-109.
52. Montz Andrée, R.; Jiménez Vicioso, A.; Coullaut Jáuregui, J,; López-Ibor Aliño J.J.; Carreras Delgado, J.L. Pet en neurología y psiquiatría I. PET con FDG en el estudio del SNC. Rev. Esp. Med. Nucl., 2002, 21, 370-386.
53. Werner, P. The need for neuroprotective therapies for Parkinsońs disease. A clinical perspective. Neurology, 2006, 66, S2-S9.
54. Esmaeilzadeh, M.; Kullingsjö, J.; Ullman, H.; Varrone, A.; Tedroff, J. Regional cerebral glucose metabolism after pridopidine (acr16) treatment in patients with Huntington disease. Clin. Neuropharmacol., 2011, 34, 95-100.
55. Kim, H.J.; Park, H.J.; Park, H.K.; Chung, J.H. Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicology, 2009, 262, 171-174.
56. Sun, L.; Gu, L.; Wang, S.; Yuan, J.; Yang, H.; Zhu, J.; Zhang, H. N-acetylcysteine Protects against Apoptosis through Modulation of Group I Metabotropic Glutamate Receptor Activity. PloS One, 2012, 7, e32503.
57. Nair, V.D.; McNaught, K.S.; Gonzalez-Maeso, J.; Sealfon, S.C.; Olanow, C.W. p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J. Biol. Chem., 2006, 281, 39550-39560.
58. Mattson, M.P. Apoptosis in neurodegenerative disorders. Nat. Rev Mol. Cell Biol., 2000, 1,120-129.
59. Bournival, J.; Quessy, P.; Martinoli, M.G. Protective effects of resveratrol and quercetin against MPP(+) -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol. Neurobiol., 2009, 29, 1169-1180.
60. Voehringer, D.W.; Meyn, R.E. Redox aspects of Bcl-2 function. Antiox. Redox. Signal., 2000, 2, 537-550.
61. Wu, A.; Liu, Y. Deltamethrin induces delayed apoptosis and altered expression of p53 and bax in rat brain. Environ. Toxicol. Pharmacol., 2000, 8, 183-189.
62. Merhi, F.; Tang, R.; Piedfer, M.; Mathieu, J.; Bombarda, I.; Zaher, M.; Kolb, J.P.; Billard, C.; Bauvois, B. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving bad and Noxa activation in human myeloid tumor cells. PLoS One, 2011, 6, e25963. doi:10.1371/journal.pone.0025963.
63. Suematsu, N.; Hosoda, M.; Fujimori, K. Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells. Neurosci. Lett., 2011, 504, 223-227.
64. Cheung, Z.H.; Leung, M.C.; Yip, H.K.; Wu, W.; Siu, F.K.; So, K.F. A neuroprotective herbal mixture inhibits caspase-3- independent apoptosis in retinal ganglion cells. Cell Mol. Neurobiol., 2008, 28,137-155.
65. Zou, Y.P.; Lu, Y.H.; Wei, D.Z. Protective effects of a flavonoidrich extract of Hypericum Perforatum L. against hydrogen peroxide-induced apoptosis in PC12 Cells. Phytother. Res., 2009, 24, S6-S10.
66. Paterniti, I.; Briguglio, E.; Mazzon, E.; Galuppo, M.; Oteri, G.; Cordasco, G.; Cuzzocrea, S. Effects of Hypericum perforatum, in a rodent model of periodontitis. BMC Complement. Altern. Med., 2010, 10, 73 doi:10.1186/1472-6882-10-73.
67. Jungke, P.; Ostrow, G.; Li, J.L.; Norton, S.; Nieber, K.; Kelber, O.; Butterweck, V. Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine. Psychopharmacology, 2011, 213,757-772.